Patent classifications
C08F222/385
CROSSLINKED POLYMER COMPOUND AND METHOD FOR PRODUCING SAME, ABSORBENT ARTICLE, DISPOSABLE DIAPER, SANITARY ARTICLE, TREATMENT CONTAINER, AND TREATMENT METHOD
The cross-linked polymer compound according to the present invention includes skeleton units of Formula (1)-(2),
##STR00001## wherein R.sup.1 is one or more selected from hydrogen, an alkyl group, a hydroxy group, an amino group, a mercapto group, a substituted carbonyl group, and any alkyl group having, as a substituent, one or more selected from a hydroxy group, an amino group, a mercapto group, and a substituted carbonyl group; X is one or more selected from —COO.sup.−, —SO.sub.3.sup.−, and —P(═O)(O.sup.−).sub.2; and Y is one or more selected from Li.sup.+, Na.sup.+, and K.sup.+, and
##STR00002## wherein R.sup.2 are each independently one or more selected from hydrogen, an alkyl group, a hydroxy group, an amino group, a mercapto group, a substituted carbonyl group, and any alkyl group having, as a substituent, one or more selected from a hydroxy group, an amino group, a mercapto group, and a substituted carbonyl group.
Method for preparing a monolithic support on which uranyl cations are immobilised, and associated methods for capture and recovery
A method for preparing, in the internal volume of at least one channel, a monolithic support on which uranyl cations are immobilised. The method comprises: (a) activating the inner surface of the channel(s); (b) introducing, into the internal volume of the channel(s), a polymerisation solution comprising: a monomer comprising a phosphate group, at least one crosslinking agent, several solvents, and a radical polymerisation initiator; (c) polymerising the polymerisation solution; (d) rinsing the monolithic support obtained in step (c); and (e) contacting the monolithic support previously rinsed, with a solution comprising uranyl cations. A method for capturing proteins that selectively bind uranium by means of a monolithic support prepared by the above-mentioned method, as well as to a method for recovering proteins that selectively bind uranium with the capture method.
Method for preparing a monolithic support on which uranyl cations are immobilised, and associated methods for capture and recovery
A method for preparing, in the internal volume of at least one channel, a monolithic support on which uranyl cations are immobilised. The method comprises: (a) activating the inner surface of the channel(s); (b) introducing, into the internal volume of the channel(s), a polymerisation solution comprising: a monomer comprising a phosphate group, at least one crosslinking agent, several solvents, and a radical polymerisation initiator; (c) polymerising the polymerisation solution; (d) rinsing the monolithic support obtained in step (c); and (e) contacting the monolithic support previously rinsed, with a solution comprising uranyl cations. A method for capturing proteins that selectively bind uranium by means of a monolithic support prepared by the above-mentioned method, as well as to a method for recovering proteins that selectively bind uranium with the capture method.
HYDROGEL
A hydrogel comprising a polymer matrix formed from a copolymer of an acrylic monomer and a crosslinkable monomer, a water-soluble polymer, water, and a polyhydric alcohol, the hydrogel having a tensile strength of 0.5 N/20 mm to 3.0 N/20 mm.
HYDROGEL
A hydrogel comprising a polymer matrix formed from a copolymer of an acrylic monomer and a crosslinkable monomer, a water-soluble polymer, water, and a polyhydric alcohol, the hydrogel having a tensile strength of 0.5 N/20 mm to 3.0 N/20 mm.
THICKENING SELF-INVERTIBLE INVERSE LATEX COMPRISING, AS AN INVERTING AGENT, SURFACTANT SPECIES OF THE POLYGLYCEROL ESTER FAMILY, AND COMPOSITIONS CONTAINING SAME
Disclosed is a self-invertible inverse latex including, as an inverting agent, surfactant species of the polyglycerol ester family; the use thereof as a thickening and/or emulsifying and/or stabilising agent for a cosmetic, dermopharmaceutical or pharmaceutical topical composition, and cosmetic, dermopharmaceutical or pharmaceutical topical compositions containing same. Also disclosed is a new surfactant composition containing polyglycerol esters.
THICKENING SELF-INVERTIBLE INVERSE LATEX COMPRISING, AS AN INVERTING AGENT, SURFACTANT SPECIES OF THE POLYGLYCEROL ESTER FAMILY, AND COMPOSITIONS CONTAINING SAME
Disclosed is a self-invertible inverse latex including, as an inverting agent, surfactant species of the polyglycerol ester family; the use thereof as a thickening and/or emulsifying and/or stabilising agent for a cosmetic, dermopharmaceutical or pharmaceutical topical composition, and cosmetic, dermopharmaceutical or pharmaceutical topical compositions containing same. Also disclosed is a new surfactant composition containing polyglycerol esters.
SUPERABSORBENT POLYMERS BASED ON COPOLYMERS OF CHARGED MONOMERS AND NEUTRAL MONOMERS
Described herein are superabsorbent polymers that are made of copolymers of multiple charged monomers, where the charged moieties of different charged monomers have different distances from copolymer backbones. The copolymer-based superabsorbent polymers have significantly improved absorbency under load. The compositions and methods described herein are useful in a variety of absorbent products.
SUPERABSORBENT POLYMERS BASED ON COPOLYMERS OF CHARGED MONOMERS AND NEUTRAL MONOMERS
Described herein are superabsorbent polymers that are made of copolymers of multiple charged monomers, where the charged moieties of different charged monomers have different distances from copolymer backbones. The copolymer-based superabsorbent polymers have significantly improved absorbency under load. The compositions and methods described herein are useful in a variety of absorbent products.
Actinic-ray-curable resin composition, gas-barrier film, and multilayer structure
An active energy ray-curable resin composition containing: a reaction product (X) of a component (A) and a component (B) below: (A) at least one selected from the group consisting of meta-xylylenediamine and para-xylylenediamine; (B) at least one selected from the group consisting of unsaturated carboxylic acids represented by the following general formula (1) and derivatives of the unsaturated carboxylic acids: ##STR00001## wherein, in the formula (1), R.sup.1 and R.sup.2 each independently represent a hydrogen atom, an alkyl group having from 1 to 8 carbon atoms, an aryl group having from 6 to 12 carbon atoms, or an aralkyl group having from 7 to 13 carbon atoms; (C) a compound having at least one group selected from the group consisting of a glycidyl group and an isocyanate group, and an ethylenically unsaturated bond-containing group; and (D) a phosphoric acid derivative having an ethylenically unsaturated bond-containing group.